Application 211090
- Type
- NDA
- Sponsor
- BIOCON PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | POWDER;INTRAVENOUS | EQ 100MG BASE/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pemetrexed | PEMETREXED DISODIUM | Sandoz Inc. | 7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3 | 2025-12-16 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Meitheal Pharmaceuticals Inc. | e0d000a3-b9d2-4fa9-9591-f7acb077481d | 2025-11-17 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Fresenius Kabi USA, LLC | ae77f00f-d43b-4b75-afd5-a2a9cb7138da | 2025-08-31 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| PEMRYDI RTU | PEMETREXED DISODIUM | Amneal Pharmaceuticals LLC | 0f006b06-ab85-423d-ba0c-dfc3fc25844e | 2025-07-08 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Somerset Therapeutics LLC | 39219e4b-80a6-4d4f-96a3-1202e542d050 | 2025-05-10 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Camber Pharmaceuticals, Inc. | 2ca1ce75-5284-4282-b76a-3700d203c714 | 2025-04-01 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Shilpa Medicare Limited | fe432994-e61b-4a87-8c98-cc20b847d0fe | 2024-11-28 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Sagent Pharmaceuticals | fa8f1f52-3f05-4ae8-bfec-7f0a029e6825 | 2024-09-30 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | NorthStar RxLLC | 64f4a9ed-26ff-4bc7-bef1-4faa98b35563 | 2024-09-10 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Meitheal Pharmaceuticals Inc. | 1ceacc3e-f555-489b-8b16-2baa58b2f5a5 | 2024-04-19 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Meitheal Pharmaceuticals Inc. | 5fb3a2d5-b9ec-4044-abb9-3e0d848a448e | 2024-04-19 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Waverley Pharma Inc | 95633c32-89a8-4275-94e7-939c9f2e6135 | 2023-12-30 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | 4cc1574b-3d2f-489b-9ad3-55695bb97200 | 2023-10-10 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Alimta | PEMETREXED DISODIUM | Eli Lilly and Company | f5a860f3-37ec-429c-ae04-9c88d7c55c08 | 2023-05-19 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | 61588f3c-4c06-4c35-a000-201dd1019093 | 2023-04-26 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | 14974d4e-2f01-4e02-aea2-c28b3ca0781c | 2023-04-26 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | Meitheal Pharmaceuticals Inc. | b185f459-5489-4e18-8521-1686b5d16f67 | 2022-12-21 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | c9f34c00-1176-4f44-8cff-bae5bdc0c40f | 2022-12-08 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
| Pemetrexed disodium | PEMETREXED DISODIUM | Dr. Reddys Laboratories Inc | 1d8bcf03-e055-a274-7844-ae9a523e3c4c | 2022-09-30 | Warnings, Adverse reactions | Pemetrexed disodium PEMETREXED DISODIUM |
| pemetrexed | PEMETREXED DISODIUM | Zydus Pharmaceuticals USA Inc. | 363665ca-db15-4123-84ac-0ae66b5f1363 | 2022-05-26 | Warnings, Adverse reactions | PEMETREXED DISODIUM |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70377-022 | Pemetrexed | Pemetrexed disodium | Biocon Pharma Inc | ANDA | Current |